You are here
Home > Centrient Pharmaceuticals

Centrient Pharmaceuticals Initiates Patent Litigation in India Against Dalas Biotech Limited

Centrient Pharmaceuticals (“Centrient”), the global leader in the production and commercialisation of sustainable, enzymatic antibiotics, next generation statins and anti-fungals, announced that it has filed a lawsuit against Dalas Biotech Limited (“Dalas”) for patent infringement. ROTTERDAM, Holland, May 01, 2019 (GLOBE NEWSWIRE) — Centrient Pharmaceuticals announced that on April 25, 2019, its wholly owned subsidiary, […]

The Delhi High Court in India has issued an injunction, restraining Sinopharm Weiqida from exporting its “Amoxycillin Trihydrate” product to India, as it infringes the patent of Centrient Pharmaceuticals

The High Court also found Sinopharm Weiqida guilty of Contempt of Court for failing to follow the previously granted preliminary injunction order ROTTERDAM, the Netherlands, Feb. 19, 2019 (GLOBE NEWSWIRE) — Centrient Pharmaceuticals (“Centrient”), the leading manufacturer of beta-lactam antibiotics, and a provider of next generation statins and anti-fungals, announced that the Delhi High Court […]

DSM Sinochem Pharmaceuticals announces its new name – Centrient Pharmaceuticals

The name, resulting from a change in ownership, reflects its role at the centre of modern healthcare ROTTERDAM, Netherlands, Dec. 10, 2018 (GLOBE NEWSWIRE) — Effective December 10, 2018 Centrient Pharmaceuticals is the new name for DSM Sinochem Pharmaceuticals, the leading manufacturer of beta-lactam antibiotics and a provider of next-generation statins and anti-fungals. The new […]

Top